Researchers from the TCGA Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer.
Dr. Gad Getz and his group at the Broad Institute of MIT and Harvard identifies 33 new cancer-causing genes and finds that the catalog of cancer genes is far from complete. Learn more about the current cancer genome landscape in this Case Study.
The Cancer Genome Atlas researchers are mapping the genetic changes in 20 cancers. Find out which cancers have been selected for study, the criteria for selection and the scientific questions being asked about each cancer.
Explore how The Cancer Genome Atlas works, the components of the TCGA Research Network and TCGA's place in the cancer genomics field in the Program Overview.
Steps Towards Precision Medicine: Utilizing FFPE Specimens for Comprehensive Genomic Characterization
Roy W. Tarnuzzer, Ph.D., the Biospecimen Core Resource Program Manager at the TCGA Program Office, provides an overview of the Formalin-fixed Paraffin Pilot Project, an initiative to investigate best practices for use of FFPE specimens in genomic studies.